ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
VIVUS Inc
0.4665
+0.0000
成交量:
- -
成交額:
- -
市值:
833.53萬
市盈率:
-0.17
高:
0.4665
開:
0.4665
低:
0.4665
收:
0.4665
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
VIVUS Inc
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.vivus.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Vivus, Inc.是一家生物製藥公司,美國FDA批准兩種治療:Qsymia慢性體重管理和STENDRA勃起功能障礙。 STENDRA也被批准由歐洲委員會,或EC,商品名,SPEDRA,勃起功能障礙在歐盟的治療。 Qsymia(芬特明和托吡酯緩釋)2012年7月被美國FDA批准,作為輔助低熱量飲食和增加了慢性體重管理的成人患者體力活動與30或初始體重指數(BMI)更大(肥胖),或27或更大(超重)中的至少一個與體重相關的合併症,如高血壓,2型糖尿病或高膽固醇(血脂異常)的存在。 Qsymia採用了專利配方,從兩個以前批準的藥品,芬特明和托吡酯結合低劑量的活性成分。雖然動作的確切機制是未知的,Qsymia被認為抑制食慾和增加飽腹感,或充滿的感覺,這種影響飲食行為的兩個主要機制。在2012年9月,通過Qsymia認證送貨上門的網絡數量有限成為美國市場上。 2013年7月,Qsymia通過約8000沃爾格林,Costco公司成為零售藥店提供杜安里德藥店nationwide.公司在美國加州於1991年成立並且於1996年重新合併在特拉華州。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/VVUS/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VVUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","market":"US","secType":"STK","nameCN":"VIVUS Inc","latestPrice":0.4665,"timestamp":1594929600000,"preClose":0.4665,"halted":4,"volume":0,"delay":0,"floatShares":14823450,"shares":17867697,"eps":-2.702649,"marketStatus":"退市","change":0,"latestTime":"04-29 18:34:42 EDT","open":0.4665,"high":0.4665,"low":0.4665,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.702649,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1745971200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":765604800000,"exchange":"NASDAQ","adjPreClose":0.4665,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","floatShares":14823450,"roa":"-2.20%","roe":"47.47%","lyrEps":-2.96053,"shares":17867697,"dividePrice":0,"high":0.4665,"amplitude":0,"preClose":0.4665,"low":0.4665,"week52Low":0.4369,"pbRate":"-0.11","week52High":4.75,"institutionHeld":0.1227,"latestPrice":0.4665,"eps":-2.702649,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.702649,"open":0.4665},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.vivus.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Vivus, Inc.是一家生物製藥公司,美國FDA批准兩種治療:Qsymia慢性體重管理和STENDRA勃起功能障礙。 STENDRA也被批准由歐洲委員會,或EC,商品名,SPEDRA,勃起功能障礙在歐盟的治療。 Qsymia(芬特明和托吡酯緩釋)2012年7月被美國FDA批准,作為輔助低熱量飲食和增加了慢性體重管理的成人患者體力活動與30或初始體重指數(BMI)更大(肥胖),或27或更大(超重)中的至少一個與體重相關的合併症,如高血壓,2型糖尿病或高膽固醇(血脂異常)的存在。 Qsymia採用了專利配方,從兩個以前批準的藥品,芬特明和托吡酯結合低劑量的活性成分。雖然動作的確切機制是未知的,Qsymia被認為抑制食慾和增加飽腹感,或充滿的感覺,這種影響飲食行為的兩個主要機制。在2012年9月,通過Qsymia認證送貨上門的網絡數量有限成為美國市場上。 2013年7月,Qsymia通過約8000沃爾格林,Costco公司成為零售藥店提供杜安里德藥店nationwide.公司在美國加州於1991年成立並且於1996年重新合併在特拉華州。","exchange":"NASDAQ","name":"VIVUS Inc","nameEN":"VIVUS Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VVUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-06","symbol":"VVUS","fiscalQuarterEnding":"2020/03","expectedEps":-0.8,"name":null,"time":"盤後","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"post","actualEps":-0.49},{"date":"2020-03-03","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.59,"defaultRemindTime":1583269200000,"name":null,"time":"盤後","dateTimestamp":1583211600000,"actualEps":null},{"date":"2019-11-05","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.62,"defaultRemindTime":1572987600000,"name":null,"time":"盤後","dateTimestamp":1572930000000,"actualEps":null},{"date":"2019-08-06","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-1,"defaultRemindTime":1565121600000,"name":null,"time":"盤後","dateTimestamp":1565064000000,"actualEps":-1.2},{"market":"US","date":"2019-04-30","symbol":"VVUS","fiscalQuarterEnding":"2019/03","expectedEps":-1.17,"name":null,"time":"盤後","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VVUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VVUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VVUS","date":"2020-07-15","current":-0.37677,"percent":0.938697,"low":-1.245839,"twenty":-0.999217,"median":-0.717023,"eighty":-0.611569,"high":-0.284472,"avg":-0.763673,"sd":0.220207,"marketCap":10838545},"quantilePoints":[{"date":"2020-05-01","current":-0.606877,"twenty":-1.037296,"median":-0.760014,"eighty":-0.638187,"marketCap":19118435},{"date":"2020-05-08","current":-0.701863,"twenty":-1.037296,"median":-0.75099,"eighty":-0.638187,"marketCap":20190497},{"date":"2020-05-15","current":-0.68323,"twenty":-1.037296,"median":-0.737327,"eighty":-0.643193,"marketCap":19654466},{"date":"2020-05-22","current":-0.73913,"twenty":-1.031879,"median":-0.738228,"eighty":-0.645695,"marketCap":21262559},{"date":"2020-05-29","current":-0.695652,"twenty":-1.027475,"median":-0.735123,"eighty":-0.651702,"marketCap":20011820},{"date":"2020-06-05","current":-0.689441,"twenty":-1.024252,"median":-0.726708,"eighty":-0.653204,"marketCap":19833143},{"date":"2020-06-12","current":-0.720497,"twenty":-1.015081,"median":-0.728747,"eighty":-0.65921,"marketCap":20726528},{"date":"2020-06-19","current":-0.645963,"twenty":-1.008831,"median":-0.723602,"eighty":-0.65921,"marketCap":18582404},{"date":"2020-06-26","current":-0.506459,"twenty":-1.007565,"median":-0.720776,"eighty":-0.645195,"marketCap":14569320},{"date":"2020-07-02","current":-0.490683,"twenty":-1.005879,"median":-0.720497,"eighty":-0.635685,"marketCap":14115480},{"date":"2020-07-10","current":-0.353168,"twenty":-1.00183,"median":-0.720312,"eighty":-0.620168,"marketCap":10159572},{"date":"2020-07-15","current":-0.37677,"twenty":-0.999217,"median":-0.717023,"eighty":-0.611569,"marketCap":10838545}],"updateTime":1745946719664}}}